These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16406697)

  • 21. Levetiracetam as add-on therapy in generalised epilepsies.
    Kumar SP; Smith PE
    Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
    Steinhoff BJ; Trinka E; Wieser HG;
    Seizure; 2005 Oct; 14(7):490-6. PubMed ID: 16169256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid onset of action of levetiracetam in refractory epilepsy patients.
    French J; Arrigo C
    Epilepsia; 2005 Feb; 46(2):324-6. PubMed ID: 15679515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
    Huang CW; Pai MC; Tsai JJ
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):548-53. PubMed ID: 18950374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
    Morrell MJ; Leppik I; French J; Ferrendelli J; Han J; Magnus L
    Epilepsy Res; 2003 May; 54(2-3):153-61. PubMed ID: 12837566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate: New preparation. Helpful in refractory partial epilepsy.
    Prescrire Int; 1999 Feb; 8(39):3-5. PubMed ID: 10557563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges.
    Stodieck S; Steinhoff BJ; Kolmsee S; van Rijckevorsel K
    Seizure; 2001 Dec; 10(8):583-7. PubMed ID: 11792161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
    Gidal BE; Baltès E; Otoul C; Perucca E
    Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.
    Cavitt J; Privitera M
    Arch Neurol; 2004 Oct; 61(10):1604-7. PubMed ID: 15477517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levetiracetam in refractory epilepsy: a prospective observational study.
    Mohanraj R; Parker PG; Stephen LJ; Brodie MJ
    Seizure; 2005 Jan; 14(1):23-7. PubMed ID: 15642496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids. Open labeled randomized prospective study.
    Mahmoud AA; Rizk TM; Mansy AA; Ali JA; Al-Tannir MA
    Neurosciences (Riyadh); 2013 Apr; 18(2):143-6. PubMed ID: 23545612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study.
    Werhahn KJ; Klimpe S; Balkaya S; Trinka E; Krämer G
    Seizure; 2011 May; 20(4):305-11. PubMed ID: 21257324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
    Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
    Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
    Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
    Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
    J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levetiracetam: new preparation. For some patients with refractory partial epilepsy.
    Prescrire Int; 2003 Apr; 12(64):53-4. PubMed ID: 12674114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.